
    
      The study was conducted as an open-label, randomized, 2-way crossover study to compare the
      single-dose relative bioavailability of Ranbaxy and GlaxoSmithKline (AugmentinÂ® 40o mg)
      amoxicillin (as the trihydrate)/57 mg clavulanic acid (as the potassium salt) chewable
      tablet, following administration of 2 tablet dose under fed conditions A total of 40
      Subjects, 20 males and 20 females; were enrolled in the study, and 39 subjects, 20 males and
      19 females, completed the study.
    
  